CYCC Archived Articles
Cyclacel Pharmaceuticals (NASDAQ:CYCC): Advancing Innovative Cancer Therapies Through Strategic Precision Medicine Approach
Published on November 17, 2024
Cyclacel Pharmaceuticals (CYCC): A Promising Oncology Biotech with Exciting Pipeline Developments
Published on September 24, 2024